» Articles » PMID: 31938135

MiR-483-3p Promotes Proliferation and Migration of Neuroblastoma Cells by Targeting PUMA

Overview
Specialty Pathology
Date 2020 Jan 16
PMID 31938135
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroblastoma is the most common extra-cranial solid tumor in infants and children and accounts for about 15% of deaths from childhood cancers. MicroRNAs (miRNAs) have been shown to play an important role in several cellular processes, such as cell proliferation, apoptosis, invasion, metastasis and angiogenesis, and therefore have been implicated in cancer progression. miR-483-3p is associated with neuroblastoma and is found to function as an 'onco-miR' in some malignancies. However, its role in neuroblastoma remains poorly understood. In this study, we confirmed that miR-483-3p is overexpressed in neuroblastoma tissue when compared with normal tissue and miR-483-3p expression is also associated with tumor stage. Overexpression of miR-483-3p substantially enhanced cell proliferation, migration, and invasion of neuroblastoma cells. miR-483-3p also promoted tumor growth of neuroblastoma . Both and experiments showed that the tumor suppressor PUMA was a target of miR-483-3p. Furthermore, down-regulation of PUMA by small interfering RNA (siRNA) exhibited similar effects to those observed as a result of overexpression of miR-483-3p. Our results indicate that miR-483-3p could function as an 'onco-miR' in human neuroblastoma and reveal a new and potentially important target for neuroblastoma anticancer therapy.

Citing Articles

Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.

Feng X, Yang L, Liu X, Liu M, Liu L, Liu J Med Oncol. 2024; 41(2):60.

PMID: 38252204 DOI: 10.1007/s12032-023-02287-0.


MiR-483-3p improves learning and memory abilities via XPO1 in Alzheimer's disease.

Luo G, Wang X, Liu C Brain Behav. 2022; 12(8):e2680.

PMID: 35833267 PMC: 9392541. DOI: 10.1002/brb3.2680.


CircFAM53B promotes the proliferation and metastasis of glioma through activating the c-MET/PI3K/AKT pathway via sponging miR-532-3p.

Pei J, Dou H, Deng X Cell Cycle. 2022; 21(5):462-476.

PMID: 35100091 PMC: 8942547. DOI: 10.1080/15384101.2021.2014738.


MiR-222-3p Promotes Cell Proliferation and Inhibits Apoptosis by Targeting PUMA (BBC3) in Non-Small Cell Lung Cancer.

Chen W, Li X Technol Cancer Res Treat. 2020; 19:1533033820922558.

PMID: 32588752 PMC: 7325542. DOI: 10.1177/1533033820922558.

References
1.
Bjornsson H, Brown L, Fallin M, Rongione M, Bibikova M, Wickham E . Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst. 2007; 99(16):1270-3. PMC: 5533193. DOI: 10.1093/jnci/djm069. View

2.
Roulston A, Muller W, Shore G . BIM, PUMA, and the achilles' heel of oncogene addiction. Sci Signal. 2013; 6(268):pe12. DOI: 10.1126/scisignal.2004113. View

3.
Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F . Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res. 2010; 70(8):3140-9. PMC: 4303586. DOI: 10.1158/0008-5472.CAN-09-4456. View

4.
Chen X, Pan M, Han L, Lu H, Hao X, Dong Q . miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Lett. 2013; 587(22):3729-37. DOI: 10.1016/j.febslet.2013.09.044. View

5.
Yang H, Li Q, Zhao W, Yuan D, Zhao H, Zhou Y . miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A. FEBS Lett. 2013; 588(1):192-7. DOI: 10.1016/j.febslet.2013.11.036. View